APOTHEEK VERLINDEN

Active

Public limited companyfounded 1986active for 40 yearsPutsebaan 24, 2040 Antwerpen, BelgiumKBO/BCE: BE 0429.633.487

Summary

APOTHEEK VERLINDEN has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €666,668 and a net result of €45,540. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 85% of 5,007 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

APOTHEEK VERLINDENActiveChecked score 91/100

Risk analysis Report Compare

Activity

Retail sale of pharmaceutical products

NACE 47730

2 sites

Size

€910,584total assets 2025

Staff: 6.3 FTE
Equity: €666,668
Profit: €45,540

Financial health

91 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

Parent: ANTWERP PHARMACIES · 100%

Accounts 29 days early0 of 9 deeds read

Why 91raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1986Equity €666,668 (73.2% of total assets)Profit of €45,540 (financial year 2025)Show the evidence

Checked score

Score 2025

91 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 62% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 98+3

equity 73.2% of total assets

Liquidity 48-5

short-term debt 26.5% · cash 6.8%

Profitability 75-5

return on assets 5.0%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)

Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.8 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit of up to €60,000 on 30-day terms is acceptable

Liquidity ample (current ratio 3.17, compared with 2.78 in 2024, above the usual 1.5; short-term debt: 26.5% and cash: 6.8% of total assets), and 26.8% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 83% on solvency, 48% on liquidity, 61% on profitability and 56% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Founded in 1986

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Equity €666,668 (73.2% of total assets)

NBB · annual accounts

Profit of €45,540 (financial year 2025)

NBB · annual accounts

Sector: Retail trade (NACE 47)

KBO

Growing equity

Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year €666,668

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

29 days early

2024

24 days early

2023

23 days early

2022

10 days early

2021

5 days late

2020

30 days late

2019

7 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 July (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

24-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

02-07-2026 Annual accounts filedfinancial year 2025 · full…
07-07-2025 Annual accounts filedfinancial year 2024 · abbreviated…
31-12-2024 Back to profitnet €79,663

Key points

Positive: Among the best 16% on solvencysector median 36.1% · 5,007 companies 73.2% View
Controlled by ANTWERP PHARMACIES 100% View
Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year: 2025
Total assets: €910,584
Profit: €45,540
Solvency: 73.2%

Total assets▲ 3.0%

Net result

20182025

Go to Financials

Board & ownership

Parent: ANTWERP PHARMACIES · 100%

Go to Board & ownership

Timeline

Events: 42
Since: 1988
Next accounts: by 31-07-2027

08-07-2024Annual accounts filed
31-12-2023Weakest financial year
21-07-2023Annual accounts filed

Go to Timeline

Company details

Sites: 2

Legal form: Public limited company
Activity: Retail sale of pharmaceutical productsNACE 47730
Founded: 20-10-1986
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about APOTHEEK VERLINDEN

What is the company number of APOTHEEK VERLINDEN?: 0429.633.487. In Belgium the VAT number is the company number with BE in front: BE 0429.633.487.
Where is APOTHEEK VERLINDEN based?: The registered office is at Putsebaan 24, 2040 Antwerpen.Company details
What does APOTHEEK VERLINDEN do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VERLINDEN?: Public limited company (NV).
When was APOTHEEK VERLINDEN founded?: On 20-10-1986.
Is APOTHEEK VERLINDEN still active?: Yes, APOTHEEK VERLINDEN is an active enterprise in the KBO register.
How many employees does APOTHEEK VERLINDEN have?: On average 6.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VERLINDEN?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK VERLINDEN profitable?: In financial year 2025, APOTHEEK VERLINDEN made a profit of €45,540.
Where can I find the annual accounts of APOTHEEK VERLINDEN?: APOTHEEK VERLINDEN filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK VERLINDEN due?: By 31-07-2027, for financial year 2026.Timeline